SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Otonomy, Inc. (OTIC) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+70488.2%).
- Analyst consensus target $6.00 (+70488.2% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 34/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — OTIC
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio4.31
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.79
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$6.00 (+70488.2%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$-0.66 |
$0.00 |
$-7.57M |
- |
| 2013 |
$-1.70 |
$0.00 |
$-19.56M |
- |
| 2014 |
$-5.46 |
$0.00 |
$-42.88M |
- |
| 2015 |
$-2.57 |
$0.00 |
$-61.67M |
- |
| 2016 |
$-3.69 |
$683K |
$-110.58M |
-16190.8% |
| 2017 |
$-2.93 |
$1.24M |
$-88.84M |
-7187.8% |
| 2018 |
$-1.61 |
$745K |
$-49.18M |
-6601.6% |
| 2019 |
$-1.42 |
$600K |
$-43.53M |
-7254.3% |
| 2020 |
$-1.07 |
$273K |
$-43.67M |
-15996% |
| 2021 |
$-0.79 |
$125K |
$-50.33M |
-40260% |
